These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15964304)

  • 1. MAPK and PI3K inhibition reduces proliferation of Barrett's adenocarcinoma in vitro.
    Vona-Davis L; Frankenberry K; Cunningham C; Riggs DR; Jackson BJ; Szwerc MF; McFadden DW
    J Surg Res; 2005 Jul; 127(1):53-8. PubMed ID: 15964304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide YY inhibits the growth of Barrett's esophageal adenocarcinoma in vitro.
    McFadden DW; Riggs DR; Jackson BJ; Vona-Davis L
    Am J Surg; 2004 Nov; 188(5):516-9. PubMed ID: 15546561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corn-derived carbohydrate inositol hexaphosphate inhibits Barrett's adenocarcinoma growth by pro-apoptotic mechanisms.
    McFadden DW; Riggs DR; Jackson BJ; Cunningham C
    Oncol Rep; 2008 Feb; 19(2):563-6. PubMed ID: 18202808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile salt exposure causes phosphatidyl-inositol-3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line.
    Jaiswal K; Tello V; Lopez-Guzman C; Nwariaku F; Anthony T; Sarosi GA
    Surgery; 2004 Aug; 136(2):160-8. PubMed ID: 15300175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells.
    Souza RF; Shewmake K; Pearson S; Sarosi GA; Feagins LA; Ramirez RD; Terada LS; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G743-8. PubMed ID: 15231484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus.
    Souza RF; Shewmake K; Terada LS; Spechler SJ
    Gastroenterology; 2002 Feb; 122(2):299-307. PubMed ID: 11832445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
    Ripple MO; Kalmadi S; Eastman A
    Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line.
    Jaiswal K; Lopez-Guzman C; Souza RF; Spechler SJ; Sarosi GA
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G335-42. PubMed ID: 16239404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silibinin inhibits cell invasion through inactivation of both PI3K-Akt and MAPK signaling pathways.
    Chen PN; Hsieh YS; Chiou HL; Chu SC
    Chem Biol Interact; 2005 Oct; 156(2-3):141-50. PubMed ID: 16169542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line.
    Keswani RN; Chumsangsri A; Mustafi R; Delgado J; Cohen EE; Bissonnette M
    Dis Esophagus; 2008; 21(6):514-21. PubMed ID: 18840136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
    Vona-Davis L; Riggs DR; Jackson BJ; McFadden DW
    J Surg Res; 2004 Jun; 119(2):143-8. PubMed ID: 15145696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keyhole limpet hemocyanin, a novel immune stimulant with promising anticancer activity in Barrett's esophageal adenocarcinoma.
    McFadden DW; Riggs DR; Jackson BJ; Vona-Davis L
    Am J Surg; 2003 Nov; 186(5):552-5. PubMed ID: 14599624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid increases MAPK-mediated proliferation in Barrett's esophageal adenocarcinoma cells via intracellular acidification through a Cl-/HCO3- exchanger.
    Sarosi GA; Jaiswal K; Herndon E; Lopez-Guzman C; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G991-7. PubMed ID: 16081761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia.
    Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of phosphatidylinositol-3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-alpha cytotoxicity.
    Zhang L; Himi T; Morita I; Murota S
    Cell Death Differ; 2001 May; 8(5):528-36. PubMed ID: 11423913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyromonas gingivalis-related cardiac cell apoptosis was majorly co-activated by p38 and extracellular signal-regulated kinase pathways.
    Lee SD; Wu CC; Kuo WW; Lin JA; Hwang JM; Lu MC; Chen LM; Hsu HH; Wang CK; Chang SH; Huang CY
    J Periodontal Res; 2006 Feb; 41(1):39-46. PubMed ID: 16409254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett's adenocarcinoma cell line.
    Morgan C; Alazawi W; Sirieix P; Freeman T; Coleman N; Fitzgerald R
    Am J Gastroenterol; 2004 Feb; 99(2):218-24. PubMed ID: 15046208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of pro-metastasis phenotypes expression in malignant pleural mesothelioma by the PI3K inhibitor LY294002 or the MEK inhibitor UO126.
    Cole GW; Alleva AM; Zuo JT; Sehgal SS; Yeow WS; Schrump DS; Nguyen DM
    Anticancer Res; 2006; 26(2A):809-21. PubMed ID: 16619474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.